Ram, E., Lavee, J., Tenenbaum, A., Klempfner, R., Fisman, E. Z., Maor, E., . . . Peled, Y. (2019). Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation. Cardiovasc Diabetol.
Chicago ZitierstilRam, Eilon, et al. "Metformin Therapy in Patients With Diabetes Mellitus Is Associated With a Reduced Risk of Vasculopathy and Cardiovascular Mortality After Heart Transplantation." Cardiovasc Diabetol 2019.
MLA ZitierstilRam, Eilon, et al. "Metformin Therapy in Patients With Diabetes Mellitus Is Associated With a Reduced Risk of Vasculopathy and Cardiovascular Mortality After Heart Transplantation." Cardiovasc Diabetol 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.